Developer docs
API playgroundTry for free, no card

Search company profiles

Hilo

Full company profile

uuid00007ww

Namestring
Hilo
Legal namestring
Aktiia SA
Websiteurl
hilo.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Hilo (formerly Aktiia) is a Swiss health technology company founded in 2018 and headquartered in Neuchâtel, with operating subsidiaries in the Netherlands and Australia. It sells a continuous, cuffless blood pressure monitoring system built around three integrated components: a medical-grade wrist-worn band that uses optical photoplethysmography (PPG) sensors and proprietary Pulse Wave Analysis algorithms to capture approximately 25 blood pressure readings per day without user intervention; an upper-arm cuff used only for initial and periodic calibration; and a companion mobile application for trend visualization, doctor-ready reports, Time-in-Target-Range metrics, and (as of February 2026) sleep and step tracking.

The system is CE Class IIa certified under EU MDR, FDA cleared, ISO 81060-2 validated, and MDSAP certified, backed by 35 patents and 4 clinical trials developed over 20+ years of scientific research. Hilo operates a hybrid hardware-plus-subscription business model: the complete monitoring system is sold bundled at £199.98 (including a 12-month membership), with annual subscription renewal at £119.99 required to retain full functionality and access to historical data. Distribution is primarily direct-to-consumer via hilo.com across 12 markets, with additional reach through authorized resellers and marketplaces (e.g., Amazon), and through clinical and insurance partnerships such as the British & Irish Hypertension Society and UnipolSai Assicurazioni. The company targets adults with hypertension or cardiovascular risk, health-conscious consumers, healthcare professionals, and enterprise/insurance partners, and reports a user base of over 120,000 across its 12 markets.

Short descriptiontext

Hilo (formerly Aktiia) is a Swiss medical-device company that sells a CE-marked and FDA-cleared cuffless wrist wearable for continuous blood pressure monitoring, paired with a mandatory annual subscription app, targeting hypertensive adults, health-conscious consumers, and healthcare and insurance partners across 12 global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNeuchâtel, Switzerland
HQ citystring
Neuchâtel
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cuffless blood pressure monitoring, wearable health technology, continuous cardiovascular monitoring, optical PPG sensors, remote patient monitoring
Industry3 codes
1Blood Pressure Monitoring (Cuff & Cuffless)
CodeHLAHACACPrimaryYes
2Hypertension & Ambulatory Blood Pressure Care
CodeHLAKABAHPrimaryNo
3Blood Pressure Monitors (Smart Cuffs)
CodeCRACAQABPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable cardiovascular health monitoring
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales (Hilo Band + Cuff)
TypeHardware Sales
Description

One-time purchase of the Hilo Band and calibration cuff, sold as a bundled system. The physical device is sold alongside a bundled 12-month subscription membership.

hilo.com
2Subscription (Hilo Membership)
TypeSubscription Recurring
Description

Recurring annual subscription model ($119.99/year renewal after initial 12-month bundled period). Required for device functionality and access to continuous monitoring, trend analysis, clinical insights, app features, and data storage. If cancelled, access is limited to last 24 hours of data for 30 days, then locked.

hilo.com
3Replacement Parts and Accessories
TypeHardware Sales
Description

Replacement hardware (bands, cuffs, charging pods) sold exclusively to existing customers through the replacement parts store.

hilo.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Hilo Blood Pressure Monitoring System - Initial Purchase
ModelHybridBilling cadenceAnnual
Notes

£199.98 initial purchase includes: Hilo Band, Hilo Cuff, charging pod/cable, and 12-month Hilo membership subscription. Renewal price: £119.99/year.

hilo.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Hilo sells a cuffless continuous blood pressure monitoring system consisting of a wearable wristband (Hilo Band) equipped with optical PPG sensors, a calibration cuff (Hilo Cuff), and a companion smartphone app (Hilo App). Blood pressure is computed continuously from optical signals via proprietary Pulse Wave Analysis algorithms, with the cuff used only periodically to recalibrate. Continuous data, historical trends, and exportable reports are unlocked through an annual Hilo Membership subscription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Users with high or very high blood pressure reduced systolic readings by up to 7 mmHg after just 6 months of monitoring with Hilo.
+4 more records
Product overview1 text field

Hilo is a comprehensive blood pressure monitoring platform comprising three integrated components: the Hilo Band (a medical-grade wearable that continuously measures blood pressure via optical sensors and Pulse Wave Analysis), the Hilo Cuff (upper-arm calibration device), and the Hilo App (mobile application for data visualization, insights, and doctor-ready reporting). The system requires an active subscription (Hilo Membership) to function, with the complete package sold as the Hilo Blood Pressure Monitoring System at £199.98 including the band, cuff, and 12-month subscription. The platform provides continuous monitoring (~25 measurements per day), automatic pattern detection linked to sleep/stress/activity, and clinical-grade accuracy validated against ISO 81060-2 standards.

Product and service2 records
1Hilo Blood Pressure Monitoring System
CategoryWearable cardiovascular health monitoring
Description

A cuffless continuous blood pressure monitoring system for individual consumers, comprising the Hilo Band wrist wearable with optical PPG sensors, a periodic-use Hilo Cuff for calibration, and the Hilo App. The product is intended for adults who want continuous, at-home blood pressure tracking and trend reporting to share with their physician.

2Hilo Membership
CategoryHealth data subscription service
Description

An annual subscription that unlocks continuous blood pressure history, trend visualization, and exportable PDF reports inside the Hilo App for users of the Hilo Band. It is sold to individual consumers who already own the Hilo hardware and want ongoing access to longitudinal monitoring data.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Formal agreement with the British & Irish Hypertension Society represents Hilo's most significant clinical partnership. BIHS is a leading professional organization advancing hypertension research and clinical practice in the UK and Ireland. The partnership validates Hilo's clinical credibility and supports healthcare professional adoption.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Listed as a trusted healthcare organization on Hilo's product page, indicating a commercial or endorsement relationship with this Italian insurance company.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

The BBC StoryWorks 'Beats of Change' documentary series, produced for Hilo, was presented by the World Heart Federation. This association positions Hilo within the global cardiovascular health advocacy community and provides high-visibility endorsement from a leading health authority.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Microlife is a long-standing manufacturer of blood pressure monitors with connected/home-monitoring products, directly competing with Hilo in the BP monitoring category across consumer and clinical channels.

TypeBroad incumbent
Description

Fitbit (owned by Google) sells health-focused wearables and is exploring blood pressure and cardiovascular features. It competes with Hilo in the health-conscious consumer segment and benefits from Google-scale data infrastructure and consumer reach.

TypeDirect peer
Description

Withings makes connected health devices including BPM Core and Connect, plus smartwatches and scales with cardiovascular features. It competes directly with Hilo in connected blood pressure monitoring for health-conscious consumers and integrates similar Apple Health/Health Connect pathways.

TypeBroad incumbent
Description

Samsung offers blood pressure and ECG monitoring on Galaxy Watch devices in select markets, positioning it as a broad incumbent competitor to Hilo in consumer-facing cardiovascular monitoring, especially outside the US.

TypeBroad incumbent
Description

Medtronic operates broadly in cardiovascular and connected health through its Cardiac Diagnostics & Services and Patient Monitoring businesses, overlapping with Hilo in clinical-grade blood pressure management and remote monitoring for hypertensive patients.

TypeDirect peer
Description

iHealth is a major player in consumer and clinical connected blood pressure monitors, offering FDA-cleared smart BP cuffs and integrated app ecosystems that directly overlap with Hilo's product offering and D2C channel.

TypeDirect peer
Description

Omron is the global leader in consumer blood pressure monitors and has been expanding into connected/smart cuffs and digital health. It directly competes with Hilo in the BP monitoring category and is the dominant incumbent against which Hilo's cuffless wearable competes.

TypeEmerging player
Description

Biobeat develops cuffless, continuous blood pressure and vital-sign monitoring wearables using PPG-based technology, similar to Hilo's Pulse Wave Analysis approach. It is one of the closest emerging competitors in the cuffless BP wearable space, focused initially on clinical/remote-patient-monitoring settings.

TypeBroad incumbent
Description

Apple launched hypertension notifications on Apple Watch and is the most consequential broad incumbent in consumer health wearables. It does not yet offer Hilo's cuffless continuous BP measurement, but its scale and watch install base make it the dominant competitive threat in the consumer-facing BP monitoring category.

TypeEmerging player
Description

AliveCor makes KardiaMobile ECG devices and is expanding into broader cardiac monitoring. While its current focus is ECG, it competes with Hilo in the consumer/professional cardiac monitoring category and shares clinical-grade positioning and D2C-plus-clinician distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hilo

Wearable cardiovascular health monitoringhilo.com

Hilo (formerly Aktiia) is a Swiss medical-device company that sells a CE-marked and FDA-cleared cuffless wrist wearable for continuous blood pressure monitoring, paired with a mandatory annual subscription app, targeting hypertensive adults, health-conscious consumers, and healthcare and insurance partners across 12 global markets.

What Hilo does

Hilo (formerly Aktiia) is a Swiss health technology company founded in 2018 and headquartered in Neuchâtel, with operating subsidiaries in the Netherlands and Australia. It sells a continuous, cuffless blood pressure monitoring system built around three integrated components: a medical-grade wrist-worn band that uses optical photoplethysmography (PPG) sensors and proprietary Pulse Wave Analysis algorithms to capture approximately 25 blood pressure readings per day without user intervention; an upper-arm cuff used only for initial and periodic calibration; and a companion mobile application for trend visualization, doctor-ready reports, Time-in-Target-Range metrics, and (as of February 2026) sleep and step tracking.

The system is CE Class IIa certified under EU MDR, FDA cleared, ISO 81060-2 validated, and MDSAP certified, backed by 35 patents and 4 clinical trials developed over 20+ years of scientific research. Hilo operates a hybrid hardware-plus-subscription business model: the complete monitoring system is sold bundled at £199.98 (including a 12-month membership), with annual subscription renewal at £119.99 required to retain full functionality and access to historical data. Distribution is primarily direct-to-consumer via hilo.com across 12 markets, with additional reach through authorized resellers and marketplaces (e.g., Amazon), and through clinical and insurance partnerships such as the British & Irish Hypertension Society and UnipolSai Assicurazioni. The company targets adults with hypertension or cardiovascular risk, health-conscious consumers, healthcare professionals, and enterprise/insurance partners, and reports a user base of over 120,000 across its 12 markets.

Hilo firmographics

Firmographics
Name
Hilo
Legal name
Aktiia SA
Website
https://hilo.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Hilo (formerly Aktiia) is a Swiss medical-device company that sells a CE-marked and FDA-cleared cuffless wrist wearable for continuous blood pressure monitoring, paired with a mandatory annual subscription app, targeting hypertensive adults, health-conscious consumers, and healthcare and insurance partners across 12 global markets.
Ownership category
akta.pro rank

Hilo industry classification

Industry
Product category
Wearable cardiovascular health monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Blood Pressure Monitoring (Cuff & Cuffless) (HLAHACAC)
akta.pro secondary industries
Hypertension & Ambulatory Blood Pressure Care (HLAKABAH), Blood Pressure Monitors (Smart Cuffs) (CRACAQAB)

Keywords

  • Cuffless blood pressure monitoring
  • Wearable health technology
  • Continuous cardiovascular monitoring
  • Optical PPG sensors
  • Remote patient monitoring

Where Hilo is headquartered

Location

Headquarters

HQ city
Neuchâtel
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Hilo business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware Sales (Hilo Band + Cuff): One-time purchase of the Hilo Band and calibration cuff, sold as a bundled system. The physical device is sold alongside a bundled 12-month subscription membership.
  2. Subscription (Hilo Membership): Recurring annual subscription model ($119.99/year renewal after initial 12-month bundled period). Required for device functionality and access to continuous monitoring, trend analysis, clinical insights, app features, and data storage. If cancelled, access is limited to last 24 hours of data for 30 days, then locked.
  3. Replacement Parts and Accessories: Replacement hardware (bands, cuffs, charging pods) sold exclusively to existing customers through the replacement parts store.

Pricing tiers

ModelBillingPrice
HybridAnnualHilo Blood Pressure Monitoring System - Initial Purchase

Go-to-market motion4 records

Distribution channels3 records

Marketing channels7 records

Hilo product offering

Product offering

Core offering

Hilo sells a cuffless continuous blood pressure monitoring system consisting of a wearable wristband (Hilo Band) equipped with optical PPG sensors, a calibration cuff (Hilo Cuff), and a companion smartphone app (Hilo App). Blood pressure is computed continuously from optical signals via proprietary Pulse Wave Analysis algorithms, with the cuff used only periodically to recalibrate. Continuous data, historical trends, and exportable reports are unlocked through an annual Hilo Membership subscription.

Product overview

Hilo is a comprehensive blood pressure monitoring platform comprising three integrated components: the Hilo Band (a medical-grade wearable that continuously measures blood pressure via optical sensors and Pulse Wave Analysis), the Hilo Cuff (upper-arm calibration device), and the Hilo App (mobile application for data visualization, insights, and doctor-ready reporting). The system requires an active subscription (Hilo Membership) to function, with the complete package sold as the Hilo Blood Pressure Monitoring System at £199.98 including the band, cuff, and 12-month subscription. The platform provides continuous monitoring (~25 measurements per day), automatic pattern detection linked to sleep/stress/activity, and clinical-grade accuracy validated against ISO 81060-2 standards.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hilo Blood Pressure Monitoring System A cuffless continuous blood pressure monitoring system for individual consumers, comprising the Hilo Band wrist wearable with optical PPG sensors, a periodic-use Hilo Cuff for calibration, and the Hilo App. The product is intended for adults who want continuous, at-home blood pressure tracking and trend reporting to share with their physician.
  • Hilo Membership An annual subscription that unlocks continuous blood pressure history, trend visualization, and exportable PDF reports inside the Hilo App for users of the Hilo Band. It is sold to individual consumers who already own the Hilo hardware and want ongoing access to longitudinal monitoring data.

Quantifiable outcome

  • Users with high or very high blood pressure reduced systolic readings by up to 7 mmHg after just 6 months of monitoring with Hilo.
  • +4 more outcomes

Companies that use Hilo

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Hilo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature6 records

Hilo partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and minor.

  • British & Irish Hypertension Society (BIHS)flagshipStrategic or Co-development Partner · 1 January 2025Formal agreement with the British & Irish Hypertension Society represents Hilo's most significant clinical partnership. BIHS is a leading professional organization advancing hypertension research and clinical practice in the UK and Ireland. The partnership validates Hilo's clinical credibility and supports healthcare professional adoption.
  • UnipolSai AssicurazioniminorGTM or Marketing PartnerListed as a trusted healthcare organization on Hilo's product page, indicating a commercial or endorsement relationship with this Italian insurance company.
  • World Heart FederationflagshipStrategic or Co-development PartnerThe BBC StoryWorks 'Beats of Change' documentary series, produced for Hilo, was presented by the World Heart Federation. This association positions Hilo within the global cardiovascular health advocacy community and provides high-visibility endorsement from a leading health authority.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Hilo competitors and assessment

Company assessment

Direct peers

  • Microlife: Microlife is a long-standing manufacturer of blood pressure monitors with connected/home-monitoring products, directly competing with Hilo in the BP monitoring category across consumer and clinical channels.
  • Withings: Withings makes connected health devices including BPM Core and Connect, plus smartwatches and scales with cardiovascular features. It competes directly with Hilo in connected blood pressure monitoring for health-conscious consumers and integrates similar Apple Health/Health Connect pathways.
  • iHealth Labs: iHealth is a major player in consumer and clinical connected blood pressure monitors, offering FDA-cleared smart BP cuffs and integrated app ecosystems that directly overlap with Hilo's product offering and D2C channel.
  • Omron Healthcare: Omron is the global leader in consumer blood pressure monitors and has been expanding into connected/smart cuffs and digital health. It directly competes with Hilo in the BP monitoring category and is the dominant incumbent against which Hilo's cuffless wearable competes.

Broad incumbents

  • Fitbit (Google): Fitbit (owned by Google) sells health-focused wearables and is exploring blood pressure and cardiovascular features. It competes with Hilo in the health-conscious consumer segment and benefits from Google-scale data infrastructure and consumer reach.
  • Samsung Health: Samsung offers blood pressure and ECG monitoring on Galaxy Watch devices in select markets, positioning it as a broad incumbent competitor to Hilo in consumer-facing cardiovascular monitoring, especially outside the US.
  • Medtronic: Medtronic operates broadly in cardiovascular and connected health through its Cardiac Diagnostics & Services and Patient Monitoring businesses, overlapping with Hilo in clinical-grade blood pressure management and remote monitoring for hypertensive patients.
  • Apple: Apple launched hypertension notifications on Apple Watch and is the most consequential broad incumbent in consumer health wearables. It does not yet offer Hilo's cuffless continuous BP measurement, but its scale and watch install base make it the dominant competitive threat in the consumer-facing BP monitoring category.

Emerging players

  • Biobeat: Biobeat develops cuffless, continuous blood pressure and vital-sign monitoring wearables using PPG-based technology, similar to Hilo's Pulse Wave Analysis approach. It is one of the closest emerging competitors in the cuffless BP wearable space, focused initially on clinical/remote-patient-monitoring settings.
  • AliveCor (Kardia): AliveCor makes KardiaMobile ECG devices and is expanding into broader cardiac monitoring. While its current focus is ECG, it competes with Hilo in the consumer/professional cardiac monitoring category and shares clinical-grade positioning and D2C-plus-clinician distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hilo social profiles

Digital presence

Hilo compliance and trust

Trust signal

Compliance6 records

Hilo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hilo leadership team

Management profile

Number of profiles

Profiles1 record

Hilo subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Hilo funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hilo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hilo

What does Hilo do?

Hilo sells a cuffless continuous blood pressure monitoring system consisting of a wearable wristband (Hilo Band) equipped with optical PPG sensors, a calibration cuff (Hilo Cuff), and a companion smartphone app (Hilo App). Blood pressure is computed continuously from optical signals via proprietary Pulse Wave Analysis algorithms, with the cuff used only periodically to recalibrate. Continuous data, historical trends, and exportable reports are unlocked through an annual Hilo Membership subscription.

Is Hilo a public or private company?

Hilo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hilo founded?

Hilo was founded in 2018. It employs 51 to 100 people.

Where is Hilo based?

Hilo is headquartered in Neuchâtel, Switzerland, in the Europe region.

How does Hilo make money?

Three revenue lines are on record. Hardware Sales (Hilo Band + Cuff) is the primary driver. The others are subscription (Hilo Membership) and replacement Parts and Accessories.

Who are Hilo's main competitors?

Direct peers on record are Microlife, Withings, iHealth Labs and Omron Healthcare. Broad incumbents are Fitbit (Google), Samsung Health, Medtronic and Apple. Emerging players are Biobeat and AliveCor (Kardia).

Does Hilo have an API?

No public API is recorded for Hilo.

What industry is Hilo in?

Hilo's product category is Wearable cardiovascular health monitoring. Its primary akta.pro industry code is HLAHACAC, Blood Pressure Monitoring (Cuff & Cuffless), with a secondary code of HLAKABAH, Hypertension & Ambulatory Blood Pressure Care. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nelson Advisors BlogHilo Cuffless Blood Pressure Monitoring System: Technology, Clinical Validation, Regulatory Trajectory and Market DynamicsHilo, formerly Aktiia SA, secured FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitoring system, marking a significant regulatory milestone in the United States market. The company recently rebranded and closed a $42 million Series B funding round, bringing total capital raised to over $119 million to support global commercial expansion. This device utilizes optical pulse wave analysis to provide continuous, non-invasive cardiovascular surveillance without traditional inflatable cuffs.The KnockturnalHilo Launch Event in New YorkHilo, a health technology brand developed by Aktiia and Hilo Core, celebrated its US launch in New York on July 21 with a brunch event at EDITION Madison Square. The first-of-its-kind blood pressure monitoring system combines a lightweight wearable band, mobile app, and FDA-cleared connected cuff to deliver continuous, long-term blood pressure insights, capturing 30–35 readings per day. Originally developed in Switzerland and backed by over two decades of research and eight clinical studies, the product aims to address the fact that nearly half of US adults have high blood pressure, creating a new category between traditional cuff-based monitors and consumer wearables.pharmaphorumSolution Spotlight: Aktiia Blood Pressure TechnologyThis article is a company profile spotlighting Aktiia, a Swiss medical technology company founded in 2018 that has developed a clinically validated medical-grade wearable for continuous 24/7 blood pressure monitoring using optical PPG sensor technology.TrendHunter.comBlood Pressure Health SystemsAktiia\'s health technology brand Hilo has launched the Hilo Core system in the United States, marketed as the first comprehensive blood pressure health system that moves beyond isolated readings to establish continuous cardiovascular monitoring. The system integrates a wearable optical sensor band, a mobile application, and an FDA-cleared connected cuff to generate an estimated 30 to 35 blood pressure measurements per day, including overnight values, contextualized with sleep, activity, and heart rate data.HLTHHilo Launches Blood Pressure Monitoring System in the U.S.Hilo has launched its Hilo Core blood pressure monitoring system in the United States, developed by Aktiia, combining a wrist-worn wearable device with an FDA-cleared connected blood pressure cuff to collect up to 35 blood pressure readings per day. The system uses photoplethysmography (PPG) technology for continuous, cuff-free monitoring throughout the day and night, integrating additional health metrics like heart rate, sleep, and activity. The U.S. launch follows Hilo's $19 million Series B extension, bringing total funding to over $119 million, with plans to continue pursuing regulatory development for the technology.Pulse 2.0Hilo Launches Blood Pressure Monitoring System In The U.S. Following $19 Million Funding ExtensionHilo, a health technology brand developed by Aktiia, has launched Hilo Core in the United States, a blood pressure monitoring system combining a wrist-worn wearable, mobile app, and FDA-cleared connected cuff using optical photoplethysmography technology. The company recently secured a $19 million extension to its Series B financing, bringing total funding to over $119 million, with the system becoming available nationwide on July 21, 2026, priced at $89.99 plus a $149.99 annual subscription. Hilo plans to develop the technology into a regulated medical platform in the future, subject to regulatory review.MobiHealthNewsHilo launches blood pressure tracker with $19M funding boostHilo, a health technology brand developed by Swiss company Aktiia, announced the U.S. launch of Hilo Core, a wearable blood pressure monitoring system that combines a wristband, mobile app, and FDA-cleared arm cuff, alongside a $19 million extension to its Series B financing that brings total funding to over $119 million. The wristband uses photoplethysmographic sensors and algorithms to estimate blood pressure after calibration with the arm cuff, collecting 30 to 35 readings daily including overnight, though it is marketed as a general wellness product rather than a medical diagnostic tool. The company plans to expand into a regulated medical platform in the future.Medical Device NetworkHilo introduces blood pressure monitoring system in USHilo, an Aktiia-developed health technology brand, has launched its Hilo Core blood pressure monitoring system in the US, combining a wearable wristband, mobile application, and FDA-cleared connected cuff that records up to 35 readings daily. The product provides continuous blood pressure tracking with contextual data on sleep, steps, and heart rate, and is pre-approved for HSA and FSA eligibility for US consumers. Hilo recently completed a $19 million Series B extension round, bringing total funding to over $119 million, with new investment from Dell Family Office and continued support from existing backers.BioAlpsHilo Raises $19 Million and Launches Wearable Blood Pressure Monitor in the USHilo launched Hilo Core, a wearable blood pressure monitor, in the US via Hilo.com and Amazon. The device uses optical sensors and PPG signals, validated in eight clinical studies and used by over 200,000 people globally. The launch follows a $19 million Series B extension, bringing total funding to over $119 million.startupticker.chHilo closes Series B extension round to fuel US expansionHilo, a health technology brand developed by Aktiia, secured a $19 million Series B extension round bringing its total funding to date to over $119 million, with new investment from Dell Family Office alongside continued support from existing backers. The company will use the funding to expand into the U.S. market and launch Hilo Core, a blood pressure monitoring system combining a wearable band, mobile app, and FDA-cleared connected cuff, available nationwide starting July 21, 2026 at $89.99 plus a $149.99 annual subscription.